Condition: Moderate to Severe Vernal Keratoconjunctivitis · Sponsor: Laboratoires Thea
The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis
This description comes directly from the study's public registry record.
Corentin LE CAMUS · +33473981436 · Corentin.LECAMUS@theapharma.com
Always discuss trial participation with your own doctor first.
| Disha Eye Hospitals - Barrackpore | Kolkata, West Bengal, India | Recruiting |
| M&J Institute of Ophthalmology | Ahmedabad, India | Recruiting |
| Netralaya Super Speciality Eye Hospital | Ahmedabad, India | Recruiting |
| Narayana Nethralaya | Bangalore, India | Recruiting |
| L. V. Prasad Eye Institute (LVPEI) | Hyderabad, India | Recruiting |
| Agrawal Hospital | Jaipur, India | Recruiting |
| Regional Institute of Ophthalmology (RIO) - Kolkata | Kolkata, India | Recruiting |
| Regional Institute of Ophthalmology, Patna | Patna, India | Recruiting |
| PBMA'S H. V. Desai Eye Hospital | Pune, India | Recruiting |
| Shivam Retina Clinic and Eye Hospital | Surat, India | Recruiting |
| L V Prasad Eye Institute | Visakhapatnam, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07169695